These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 8789977)

  • 21. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team.
    Høgh B; Clarke PD; Camus D; Nothdurft HD; Overbosch D; Günther M; Joubert I; Kain KC; Shaw D; Roskell NS; Chulay JD;
    Lancet; 2000 Dec; 356(9245):1888-94. PubMed ID: 11130385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malaria chemoprophylaxis in travellers to east Africa: a comparative prospective study of chloroquine plus proguanil with chloroquine plus sulfadoxine-pyrimethamine.
    Fogh S; Schapira A; Bygbjerg IC; Jepsen S; Mordhorst CH; Kuijlen K; Ravn P; Rønn A; Gøtzsche PC
    Br Med J (Clin Res Ed); 1988 Mar; 296(6625):820-2. PubMed ID: 3130927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malaria at Christmas: risks of prophylaxis versus risks of malaria.
    Reid AJ; Whitty CJ; Ayles HM; Jennings RM; Bovill BA; Felton JM; Behrens RH; Bryceson AD; Mabey DC
    BMJ; 1998 Nov; 317(7171):1506-8. PubMed ID: 9831584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmaceutical care for international voyagers: prophylaxis including chloroquine plus proguanil].
    Hernández Tintorer JL; Lorduy Osés L
    Farm Hosp; 2004; 28(2):137-40. PubMed ID: 15101806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse events associated with mefloquine. Risk-benefit ratio must be taken into account.
    Dollow S
    BMJ; 1996 Dec; 313(7071):1553; author reply 1554. PubMed ID: 8978258
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy.
    Phillips-Howard PA; Steffen R; Kerr L; Vanhauwere B; Schildknecht J; Fuchs E; Edwards R
    J Travel Med; 1998 Sep; 5(3):121-6. PubMed ID: 9772329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
    Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR
    Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuro-psychiatric effects of antimalarials.
    van Riemsdijk MM; van der Klauw MM; van Heest JA; Reedeker FR; Ligthelm RJ; Herings RM; Stricker BH
    Eur J Clin Pharmacol; 1997; 52(1):1-6. PubMed ID: 9143859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malaria chemoprophylaxis.
    Milord F; Allard R; Gyorkos TW
    Lancet; 1993 Aug; 342(8869):502. PubMed ID: 8102463
    [No Abstract]   [Full Text] [Related]  

  • 31. Utilisation of malaria prophylaxis: the effect of changes in guidelines in The Netherlands, 1993-1998.
    van Riemsdijk MM; Sturkenboom MC; Schilthuis HJ; Stricker BH
    Pharm World Sci; 2003 Feb; 25(1):21-4. PubMed ID: 12661472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Duodenal ulcers caused by chloroquine-proguanil association].
    Roux X; Imbert P; Rivière F; Méchaï F; Rapp C
    Med Trop (Mars); 2010 Dec; 70(5-6):423-4. PubMed ID: 21520638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimalarial prophylaxis--use and adverse events in visitors to the Kruger National Park.
    Durrheim DN; Gammon S; Waner S; Braack LE
    S Afr Med J; 1999 Feb; 89(2):170-5. PubMed ID: 10191871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Malaria chemoprophylaxis].
    Petersen JE
    Ugeskr Laeger; 2005 Oct; 167(42):3984-7. PubMed ID: 16232397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of malaria prevention measures by North American and European travelers to East Africa.
    Lobel HO; Baker MA; Gras FA; Stennies GM; Meerburg P; Hiemstra E; Parise M; Odero M; Waiyaki P
    J Travel Med; 2001; 8(4):167-72. PubMed ID: 11703900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
    Overbosch D; Schilthuis H; Bienzle U; Behrens RH; Kain KC; Clarke PD; Toovey S; Knobloch J; Nothdurft HD; Shaw D; Roskell NS; Chulay JD;
    Clin Infect Dis; 2001 Oct; 33(7):1015-21. PubMed ID: 11528574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerability of doxycycline monohydrate salt vs. chloroquine-proguanil in malaria chemoprophylaxis.
    Pagès F; Boutin JP; Meynard JB; Keundjian A; Ryfer S; Giurato L; Baudon D
    Trop Med Int Health; 2002 Nov; 7(11):919-24. PubMed ID: 12390596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A severe adverse reaction to mefloquine and chloroquine prophylaxis.
    Lysack JT; Lysack CL; Kvern BL
    Aust Fam Physician; 1998 Dec; 27(12):1119-20. PubMed ID: 9919736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials.
    Meier CR; Wilcock K; Jick SS
    Drug Saf; 2004; 27(3):203-13. PubMed ID: 14756582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of chemoprophylaxis on the timing of onset of falciparum malaria.
    Reyburn H; Behrens RH; Warhurst D; Bradley D
    Trop Med Int Health; 1998 Apr; 3(4):281-5. PubMed ID: 9623928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.